Lv1
30 积分 2023-11-25 加入
Recent Progress of METTL3 Inhibitors for Cancer Therapeutics: Design, Optimization and Potential Applications
17小时前
待确认
Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells
5天前
已完结
Single‐cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia
5天前
已完结
Oncogenic activation of EVC/EVC2 defines a therapeutically targetable subset of acute myeloid leukemia
5天前
已完结
Olverembatinib in chronic myeloid leukemia—Review of historical development, current status, and future research
6天前
已完结
Chronic Myeloid Leukemia
8天前
已完结
The path to venetoclax resistance is paved with mutations, metabolism, and more
11天前
已完结
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study
12天前
已完结
USP5 inhibition enables potential therapy for t(8;21) AML through ubiquitin-mediated AML1-ETO degradation in patient-derived xenografts
14天前
已完结
Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma
15天前
已关闭
皖公网安备34019202002308
